Mitochondria: An emerging target for therapeutics

Clinical Pharmacology and Therapeutics

Volumn 87, Issue 6, 2010, Pages 630-632

  Hersh, S P ^a  

^a Marriott Mitochondrial Disorders Clinical Research Project   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

AMINO ACID METABOLISM; APOPTOSIS; BIOENGINEERING; BIPOLAR DISORDER; CLINICAL RESEARCH; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG TARGETING; FOOD AND DRUG ADMINISTRATION; HOMEOSTASIS; HUMAN; LIPID METABOLISM; MEDICAL SOCIETY; MITOCHONDRION; NEUROMUSCULAR DISEASE; NITROGEN METABOLISM; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG DISCOVERY; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; RESEARCH;

EID: 77952560952     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.22     Document Type: Short Survey

References (2)

1. Harding, A.E. Growing old: the most common mitochondrial disease of all? Nat. Genet. 2, 251-252 (1992).
2. Area-Gomez, E. et al. Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. Am. J. Pathol. 175, 1810-1816 (2009).